Protection against melanoma by vaccination with Bacille Calmette-Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control
- 1 January 2005
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (1) , 104-117
- https://doi.org/10.1016/j.ejca.2004.08.010
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Impact of vaccinations and infectious diseases on the risk of melanoma—evaluation of an EORTC case–control studyEuropean Journal Of Cancer, 2003
- Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM StudyJournal of Investigative Dermatology, 2002
- Daycare attendance and risk of childhood acute lymphoblastic leukaemiaBritish Journal of Cancer, 2002
- Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control studyBritish Journal of Cancer, 2002
- Infections and melanoma riskMelanoma Research, 1999
- Potential role of environmental factors in the etiology and pathogenesis of atopy: a working model.Environmental Health Perspectives, 1999
- 5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMAJournal of Urology, 1999
- Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781)European Journal Of Cancer, 1993
- The ClassicClinical Orthopaedics and Related Research, 1991
- BCG vaccination and cancerTubercle, 1990